These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12528775)

  • 1. Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts.
    Silberman S; Joensuu H
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S66-9. PubMed ID: 12528775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.
    van Oosterom AT; Judson IR; Verweij J; Stroobants S; Dumez H; Donato di Paola E; Sciot R; Van Glabbeke M; Dimitrijevic S; Nielsen OS;
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S83-7. PubMed ID: 12528778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
    Demetri GD
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumors: rationale for surgical adjuvant trials with imatinib.
    Cormier JN; Patel SR; Pisters PW
    Curr Oncol Rep; 2002 Nov; 4(6):504-9. PubMed ID: 12354363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).
    Van den Abbeele AD; Badawi RD
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S60-5. PubMed ID: 12528774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors.
    Eisenberg BL
    Oncology (Williston Park); 2003 Nov; 17(11):1615-20; discussion 1620, 1623, 1626 passim. PubMed ID: 14682111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors: chemotherapy and imatinib.
    Muler JH; Baker L; Zalupski MM
    Curr Oncol Rep; 2002 Nov; 4(6):499-503. PubMed ID: 12354362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: a report of two cases.
    Hasan S; Hassan M; Oke L; Dinh K; Onojobi G; Lombardo F; Dawkins F; Jack M
    J Natl Med Assoc; 2003 Dec; 95(12):1208-10. PubMed ID: 14717479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
    Dagher R; Cohen M; Williams G; Rothmann M; Gobburu J; Robbie G; Rahman A; Chen G; Staten A; Griebel D; Pazdur R
    Clin Cancer Res; 2002 Oct; 8(10):3034-8. PubMed ID: 12374669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal stromal tumours.
    Connolly EM; Gaffney E; Reynolds JV
    Br J Surg; 2003 Oct; 90(10):1178-86. PubMed ID: 14515284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of imatinib (STI571).
    Buchdunger E; O'Reilly T; Wood J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S28-36. PubMed ID: 12528770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of imatinib treatment of gastrointestinal stromal tumors].
    Eckhardt S; Pápai Z; Bodoky G; Horti J; Tamás K; Nagy T; Orosz Z; Sápi Z; Gödény M; Jakab K; Esik O; Trón L; Besznyák I
    Orv Hetil; 2003 Nov; 144(45):2207-12. PubMed ID: 14686005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function.
    Bauer S; Hagen V; Pielken HJ; Bojko P; Seeber S; Schütte J
    Anticancer Drugs; 2002 Sep; 13(8):847-9. PubMed ID: 12394270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors.
    George S; Desai J
    Curr Treat Options Oncol; 2002 Dec; 3(6):489-96. PubMed ID: 12392638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study.
    van Oosterom AT; Judson I; Verweij J; Stroobants S; Donato di Paola E; Dimitrijevic S; Martens M; Webb A; Sciot R; Van Glabbeke M; Silberman S; Nielsen OS;
    Lancet; 2001 Oct; 358(9291):1421-3. PubMed ID: 11705489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?
    Scaife CL; Hunt KK; Patel SR; Benjamin RS; Burgess MA; Chen LL; Trent J; Raymond AK; Cormier JN; Pisters PW; Pollock RE; Feig BW
    Am J Surg; 2003 Dec; 186(6):665-9. PubMed ID: 14672776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of gastrointestinal stromal tumours.
    Eisenberg BL; von Mehren M
    Expert Opin Pharmacother; 2003 Jun; 4(6):869-74. PubMed ID: 12783584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefit of intermittent administration of imatinib in a patient with metastatic gastrointestinal stromal tumour.
    Morabito A; Longo R; Carillio G; Bonginelli P; Vitale S; Gasparini G
    Clin Oncol (R Coll Radiol); 2005 Apr; 17(2):96-7. PubMed ID: 15830571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neo-adjuvant STI571 therapy for high-risk gastrointestinal stromal tumour.
    Liu CL; Huang MJ; Lin SC; Chang KM; Tzen CY
    ANZ J Surg; 2004 Apr; 74(4):289-90. PubMed ID: 15043750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.